UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
BIOVIE INC. |
||
| (Exact name of registrant as specified in its charter) |
| Nevada | 46-2510769 | |
| (State or other jurisdiction of incorporation | (I.R.S. Employer | |
| or organization) | Identification No.) | |
| 680 W Nye Lane Suite 201 | ||
| Carson City, Nevada | 89703 | |
| (Address of principal executive offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
Title of each class to be registered |
Name of each exchange on which each class is to be registered |
| Warrants to purchase Class A common Stock, par value $.0001 per share | The NASDAQ Stock Market, LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), please check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), please check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement number or Regulation A offering statement number to which this form relates: 333-288525 (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act: None.
| Item 1. | Description of Registrant's Securities to be Registered. |
This registration statement relates to the registration with the Securities and Exchange Commission (the “Commission”) of warrants to purchase shares of shares of Class A common stock, par value $0.0001 per share (the “Warrants”), of BioVie Inc. (the “Registrant”). The description of the Warrants being registered pursuant to this Form 8-A that is set forth under the heading “Description of Securities” in the prospectus contained in the Registrant’s Registration Statement on Form S-1 (Registration No. 333-288525), as initially filed with the Commission on July 3, 2025 and as subsequently amended (the “Registration Statement”), is incorporated by reference into this Form 8-A. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are subsequently filed are hereby also incorporated by reference herein.
| Item 2. | Exhibits |
Pursuant to the instructions as to Exhibits of Form 8-A, the following have been filed as exhibits to the Registration Statement and are incorporated herein by reference:
-1-
-2-
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
| BIOVIE INC. | ||
| Date: August 6, 2025 | By: | /s/ Joanne Wendy Kim |
| Name: Joanne Wendy Kim | ||
| Title: Chief Financial Officer | ||
-3-